3-rx.comCustomer Support
3-rx.com
   
HomeAbout UsFAQContactHelp
News Center
Health Centers
Medical Encyclopedia
Drugs & Medications
Diseases & Conditions
Medical Symptoms
Med. Tests & Exams
Surgery & Procedures
Injuries & Wounds
Diet & Nutrition
Special Topics



\"$alt_text\"');"); } else { echo"\"$alt_text\""; } ?>


Join our Mailing List





Syndicate

You are here : 3-RX.com > Home > Cancer -

Vitamin D may cut risk of colorectal cancer

CancerFeb 10, 07

Taking 1,000 to 2,000 international units (IU) of vitamin D each day may safely reduce the risk of colorectal cancer, according to pooled data from published studies.

The current findings contradict some prior individual studies that found that vitamin D intake did not seem to protect against colorectal cancer. However, it is possible that the dose may simply have been too low to provide a benefit, researchers say.

The present analysis, reported in the American Journal of Preventive Medicine, included data from five studies that looked at the association between blood levels of 25-hydroxy-vitamin D, which provides a good estimate of vitamin D levels in the body, and colorectal cancer risk.

Dr. Edward D. Gorham, from the Naval Health Research Center in San Diego, California, and colleagues found that as blood levels of vitamin D rose, the risk of colorectal cancer fell. Risk was reduced by 54 percent in groups with the highest vitamin D levels relative to those with the lowest levels.

In the final analysis, a blood level of 33 nanograms per milliliter (ng/mL) or higher was associated with a 50 percent decreased risk of colorectal cancer relative to a level of 12 ng/mL or lower.

The researchers believe that the target blood levels could be achieved with intake of 1,000 to 2,000 IU of vitamin D per day. Moreover, they note that the National Academy of Sciences has established that a dose of 2,000 IU/day is safe.

SOURCE: American Journal of Preventive Medicine, March 2007.



Print Version
Tell-a-Friend
comments powered by Disqus

RELATED ARTICLES:
  New biomarkers may influence drug design and alternative treatments of cancer, study shows
  Metabolic profiles distinguish early stage ovarian cancer with unprecedented accuracy
  Moffitt researchers develop first genetic test to predict tumor sensitivity to radiation therapy
  New drug for neuroblastoma shows promise in phase I study
  Experimental treatment sends deadly leukemia into remission
  Study could reduce unnecessary cancer screening
  UA researchers discover component of cinnamon prevents colorectal cancer in mice
  Profiling approach to enable right lung cancer treatment match
  Fat grafting technique improves results of breast augmentation
  Germline TP53 mutations in patients with early-onset colorectal cancer
  Clinical trial suggests combination therapy is best for low-grade brain tumors
  UW research shows sensor technology may help improve accuracy of clinical breast exams

 












Home | About Us | FAQ | Contact | Advertising Policy | Privacy Policy | Bookmark Site